Ideal Healthcare Audiences
Precise target segments are built against your unique patient definitions and brand objectives and are guaranteed to exceed your audience quality goals.
Every therapy is specialized and each brand is unique so we don’t believe in traditional condition-based segments. We seek to understand your challenges and business goals when designing custom audiences. Whether you are a market leader, a new entrant facing adherence challenges or planning to execute a multi-product strategy, we can help you drive results.
We maintain the industry's highest standard of performance markers as validated by third parties. And if you reveal your Audience Quality (AQ) Benchmark upfront, we guarantee to meet or exceed it. Higher AQ drives greater engagement, optimizes conversion and ultimately increases script lift, as well as boosts therapy adherence and thus patient lifetime value.
We're the first consumer health data company to become a member of the NAI. Swoop also pioneered and patented a HIPAA-compliant privacy by design data architecture and founded our own Patient Advocacy and Privacy Board. We ensure 100% compliance with all laws, policies and guidelines.
Our data scientists, analytics and delivery professionals are industry experts traditionally found in top tier-healthcare, consulting and marketing firms
Our proprietary data curation, signals detection, and audience building methods are grounded in the experience refined from creating over 3,000 custom segments
We deploy deep learning, artificial intelligence and evolutionary computation to transform noisy and unconnected real world data into privacy-safe audiences
Our Real World Data Universe consists of 300M de-identified patients and 65B social determinants of health signals with a 10-year lookback, refreshed monthly
For too long, the healthcare and life sciences industry has been constrained by the antiquated thinking, processes and systems of a marketplace that produces broad, generic, one-size-fits-all DTC and HCP audiences. Simply put, conventional technology, data and service companies have failed to consider a brand’s specific market definitions, core therapeutic advantages and audience quality goals up front. The result? An undifferentiated message that broadly reaches too many or even the wrong targets that never actually convert and drive Rx lift.
Exclusive Patient Audiences
Of the Top 50 Pharmaceutical Brands
Of the Top 20 Healthcare Agencies
Our exclusive patient and health care provider audiences can be deployed across channels via the industry's widest variety of engagement options.
We align with the leading agencies and best minds in the programmatic, digital marketing, advertising and communications industry.
By partnering with Swoop, Abbott gained a 13x Return on Marketing Investment to educate and activate patients who could benefit from its surgical treatment for mitral regurgitation (MR)
Through Swoop, a leading pharmaceutical company refined its targeting strategy so that for every impression that went to a diagnosed patient, two were directed to diagnosed patients who were commercially insured and three to those seeking HCPs.
With Swoop's help, a large pharmaceutical company was able to migrate from a single messaging set for HCPs and patients to definitive loyal and competitive market segments with coordinated message differentiation.
Swoop helped a top pharmaceutical company refine its NPI list based on Real World Data of HCP prescribing and diagnosing patters to focus a greater portion of its investment on the highest priority HCPs for optimal campaign performance.
After partnering with Swoop to successfully enter a competitive category by targeting high-value HCPs, a leading pharmaceutical company renewed their campaign with a 10x increase in budget.